NASDAQ: BNGOBionano Genomics Inc Stock Ownership - Who owns Bionano Genomics?
Insider buying vs selling
Have Bionano Genomics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Alka Chaubey | Chief Medical Officer | 2025-09-11 | 51 | $4.06 | $207.06Sell |
| Mark Oldakowski | Chief Operating Officer | 2025-09-11 | 59 | $4.06 | $239.54Sell |
| Mark Oldakowski | Chief Operating Officer | 2025-09-11 | 59 | $4.06 | $239.54Sell |
| Jonathan V. Dixon | General Counsel | 2025-06-03 | 25 | $3.69 | $92.25Sell |
| Alka Chaubey | Chief Medical Officer | 2025-06-03 | 24 | $3.69 | $88.56Sell |
| R. Erik Holmlin | President and CEO | 2025-06-03 | 75 | $3.69 | $276.75Sell |
| Mark Oldakowski | Chief Operating Officer | 2025-06-03 | 27 | $3.69 | $99.63Sell |
| Mark Adamchak | Principal Accounting Officer | 2025-06-03 | 7 | $3.69 | $25.83Sell |
| R. Erik Holmlin | President and CEO | 2025-03-14 | 198 | $3.47 | $687.06Sell |
| R. Erik Holmlin | President and CEO | 2025-02-15 | 51 | $5.73 | $292.23Sell |
BNGO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when BNGO insiders and whales buy or sell their stock.
BNGO Shareholders
What type of owners hold Bionano Genomics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Quan Zhou | 55.70% | 5,668,017 | $8.62M | Insider |
| LC Fund VI LP | 55.70% | 5,668,017 | $8.62M | Insider |
| Junfeng Wang | 55.70% | 5,668,017 | $8.62M | Insider |
| Soheil Shams | 49.20% | 5,006,479 | $7.61M | Insider |
| Rosy Shine Ltd | 11.14% | 1,134,000 | $1.72M | Insider |
| Wealth Strategy Holding Ltd | 9.58% | 975,000 | $1.48M | Insider |
| Domain Partners VIII LP | 9.28% | 943,878 | $1.43M | Insider |
| Christopher P. Stewart | 2.77% | 281,373 | $427.69k | Insider |
| Han Phd Cao | 1.11% | 112,936 | $171.66k | Insider |
| Christopher J. Twomey | 0.73% | 74,500 | $113.24k | Insider |
BNGO vs Medical Stocks
Bionano Genomics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.